See the source article by following the link below:
The gene-editing technology CRISPR–Cas has been used for the first time in human embryos grown in vitro to correct a disease-associated mutation
The gene-editing technology CRISPR–Cas has been used for the first time in human embryos grown in vitro to correct a disease-associated mutation
No comments:
Post a Comment